Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Using the Oxytosis/Ferroptosis Pathway to Understand and Treat Age-Associated Neurodegenerative Diseases

Cell chemical biology(2020)10.1016/j.chembiol.2020.10.010Source: DataRank Database

Using the Oxytosis/Ferroptosis Pathway to Understand and Treat Age-Associated Neurodegenerative Diseases is a research paper published in Cell chemical biology (2020). On theSindex it has a DataRank of 0. It has been cited 107 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access107 citations

Download PDF

Cite:

Linked data & code

gen nct doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (7 grants)Impact (FWCI 6.36)OA: bronzeTopics (43)IDs (PubMed, PMC, OpenAlex)Annotations (3)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (3)

António Currais ORCID,David Schubert ORCID,Pamela Maher ORCID

Live enrichment

PubMed:33176157 PMC:PMC7749085 OpenAlex:https://openalex.org/W3105907500

NIA NIH HHS

Grant: R01 AG046153

NIAID NIH HHS

Grant: R41 AI104034

NIA NIH HHS

Grant: RF1 AG054714

National Institutes of Health

Grant: 1RF1AG054714-01A1

The Contribution of Old Age-Associated Proteotoxicity to Inflammation and Dementia

National Institutes of Health

Grant: 5R41AI104034-02

Modulation of the Innate Immune System by Fisetin for the Treatment of AD

Edward N. and Della L. Thome Memorial Foundation

National Institutes of Health

FWCI

6.36

Citation Percentile

1.0%

Citation Trend

2020

2021

2022

2023

2024

2025

2026

bronzeLicense: Elsevier Non-Commercial

journalhttp://www.cell.com/article/S2451945620304268/pdf

publisherhttp://www.cell.com/article/S2451945620304268/pdf

publisherhttps://api.elsevier.com/content/article/PII:S2451945620304268?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2451945620304268?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.chembiol.2020.10.010

Fields of Study

Ferroptosis and cancer prognosisRNA modifications and cancerEpigenetics and DNA Methylation0301 basic medicine0303 health sciences03 medical and health sciences

MeSH Terms

FerroptosisAnimalsClinical Trials as TopicHumansNeurodegenerative DiseasesMolecular Targeted Therapy

Keywords

DiseaseGlutamate receptorNeuroprotectionNeuroscienceReactive oxygen speciesProgrammed cell deathDrugMedicinePathophysiologyDrug discoveryBiologyBioinformaticsPharmacologyCell biologyGeneticsPathologyReceptorApoptosisMitochondriaGlutathioneCalciumOxidative stressGlutamate ToxicityGlutathione Peroxidase 4LipoxygenasesClinical Trials as TopicAnimalsFerroptosisHumansNeurodegenerative DiseasesMolecular Targeted Therapy

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being

Using the Oxytosis/Ferroptosis Pathway to Understand and Treat Age-Associated Neurodegenerative Diseases

FAIR Checklist

Authors (3)

Funding (7 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)